Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$41.8M
+792.9% from 2023
Prescriptions
5,488
$7,622.64 per claim
Patients
1,302
1,155 prescribers
Total spending, 2024
$41.8M
$32,129.83 per patient
Medicare prescription drug plans paid $41.8M for Pazopanib Hcl in 2024, for 5,488 prescriptions and refills to 1,302 patients (up 792.9% from 2023). The average cost per claim was $7,622.64.
California had the highest Medicare cost for Pazopanib Hcl in 2024: $4.9M for 754 claims, followed by Texas ($3.2M).
Melissa A Burgess, hematology-oncology in Pittsburgh, PA, had the highest Medicare cost for Pazopanib Hcl in 2024: 52 claims costing $469K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Melissa A Burgess Pittsburgh, PA | Hematology-Oncology | 52 | Under 11 | $469K |
| Joseph G Parambil Cleveland, OH | Pulmonary Disease | 64 | Under 11 | $409K |
| Gina Z D'Amato |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 317 | 530 | 352 | $4.7M |
| 2024 | 1,155 | 5,488 | 1,302 | $41.8M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 25 |
| Under 11 |
| $306K |
| Mia C Weiss Saint Louis, MO | Medical Oncology | 30 | Under 11 | $274K |
| William L Read Atlanta, GA | Hematology-Oncology | 36 | 11 | $267K |
| Richard F Riedel Durham, NC | Medical Oncology | 28 | Under 11 | $261K |
| Kamal N Ummed Atlanta, GA | Hematology-Oncology | 22 | Under 11 | $218K |
| Sripriya Santhanam Temple, TX | Hematology-Oncology | 14 | Under 11 | $210K |
| Nam Q Bui Stanford, CA | Internal Medicine | 22 | Under 11 | $205K |
| Bethany Eubanks Birmingham, AL | Nurse Practitioner | 20 | Under 11 | $191K |
| Joanna Grabska Greenville, SC | Hematology-Oncology | 12 | Under 11 | $180K |
| Arun S Singh Santa Monica, CA | Hematology-Oncology | 21 | Under 11 | $177K |
| Helda Bacall Detroit, MI | Nurse Practitioner | 26 | Under 11 | $173K |
| Lynn M Sievert Clifton Springs, NY | Nurse Practitioner | 26 | Under 11 | $173K |
| Robert M Conry Anniston, AL | Hematology-Oncology | 35 | Under 11 | $172K |
| Mitchell F Peabody Tallahassee, FL | Hematology-Oncology | 15 | Under 11 | $172K |
| Sharon A Levandowski Midland, MI | Hematology-Oncology | 19 | Under 11 | $168K |
| Robert J Christie Arlington, VA | Hematology-Oncology | 12 | Under 11 | $167K |
| Harshraj Leuva Bellevue, NE | Hematology | 14 | Under 11 | $167K |
| Zening He El Paso, TX | Hematology-Oncology | 14 | Under 11 | $166K |
| Muhammad H Isa Fort Worth, TX | Internal Medicine | 12 | Under 11 | $165K |
| Sam O Wanko Bethesda, MD | Hematology-Oncology | 12 | Under 11 | $163K |
| Michael P Sherman Walnut Creek, CA | Hematology-Oncology | 12 | Under 11 | $162K |
| Dale R Shepard Cleveland, OH | Medical Oncology | 25 | Under 11 | $157K |
| Jacob N Stein Chapel Hill, NC | Hematology-Oncology | 19 | Under 11 | $155K |
| Spending |
|---|
| Sun Pharmaceuti SUNPHARMA.NS | 2,366 | $17.8M |
| Teva Pharm TEVA | 1,509 | $11.7M |
| Apotex Corp | 1,168 | $9.2M |
| Novugen Pharma | 445 | $3.1M |